Posted by Michael Wonder on 30 Apr 2026
MHRA delivers its targets to increase access to medicines and reinforce UK position as a global destination for life sciences
28 April 2026 - The MHRA continues to speed up access to medicines for patients, increase efficiency of regulation and help to attract innovation and investment in the UK’s thriving £100 billion life sciences industry.
The MHRA met or exceeded all statutory targets to increase access to medicines and medical devices for UK patients, according to the MHRA Results and Forecast report published today.
